Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1)
Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card. The blood sample is analysed by one of 13 newborn screening laboratories in England
Buyer
NHS England
Value
£1,677,290
Published
27 Aug 2025
Closes
31 Mar 2025
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Selective
Category
Services
Contract starts
31 Mar 2025
Contract ends
31 Mar 2027
CPV classifications
33696200
Blood-testing reagents
Lots
Lot default Commercial Kit for screening for hereditary tyrosinemia type 1 (HT1)
£1,677,290
Newborn Blood Spot screening (NBS) is a national programme offered to all babies born in the UK, and it currently screens for 9 rare but potentially lethal conditions. The blood spot screening sample is taken from the baby's heel collected on a filter paper dried blood spot (DBS) card. The blood sample is analysed by one of 13 newborn screening laboratories...
Delivery: England · United Kingdom, England, United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
27 Aug 2025
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.